Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.135 AUD -5.26% Market Closed
Market Cap: 39.4m AUD
Have any thoughts about
Next Science Ltd?
Write Note

Next Science Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Next Science Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Next Science Ltd
ASX:NXS
Long-Term Debt
$687.2k
CAGR 3-Years
81%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nanosonics Ltd
ASX:NAN
Long-Term Debt
AU$6.2m
CAGR 3-Years
83%
CAGR 5-Years
141%
CAGR 10-Years
-3%
Polynovo Ltd
ASX:PNV
Long-Term Debt
AU$12.8m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SDI Ltd
ASX:SDI
Long-Term Debt
AU$16.3m
CAGR 3-Years
136%
CAGR 5-Years
N/A
CAGR 10-Years
15%
Anteris Technologies Ltd
ASX:AVR
Long-Term Debt
AU$1.5m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ansell Ltd
ASX:ANN
Long-Term Debt
$779.7m
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
1%
No Stocks Found

Next Science Ltd
Glance View

Market Cap
39.4m AUD
Industry
Health Care

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

NXS Intrinsic Value
1.454 AUD
Undervaluation 91%
Intrinsic Value
Price

See Also

What is Next Science Ltd's Long-Term Debt?
Long-Term Debt
687.2k USD

Based on the financial report for Dec 31, 2023, Next Science Ltd's Long-Term Debt amounts to 687.2k USD.

What is Next Science Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
81%

Over the last year, the Long-Term Debt growth was -29%. The average annual Long-Term Debt growth rates for Next Science Ltd have been 81% over the past three years .

Back to Top